Characteristics of IVF patients before treatment: where do we start?

Characteristics of IVF patients before treatment: where do we start?

Detalhes bibliográficos
Main Authors:	Walsh, A, Collins, G, Walsh, D, Sills, E
Formato:	Journal article
Publicado em:	2010

Registos relacionados

Pre-treatment preferences and characteristics among patients seeking in vitro fertilisation.
Por: Walsh, A, et al.
Publicado em: (2009)

Application of EU tissue and cell directive screening protocols to anonymous oocyte donors in western Ukraine: data from an Irish IVF programme.
Por: Walsh, A, et al.
Publicado em: (2010)

Bivariate analysis of basal serum anti-Mullerian hormone measurements and human blastocyst development after IVF.
Por: Sills, E, et al.
Publicado em: (2011)

Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?
Por: Lívia do Carmo Silva, et al.
Publicado em: (2020-11-01)

A hole revolution, or are we back where we started?
Por: Pooley, O
Publicado em: (2006)

Pre-treatment preferences and characteristics among patients seeking in vitro fertilisation
Por: Walsh David J, et al.
Publicado em: (2009-12-01)

Recipient screening in IVF: First data from women undergoing anonymous oocyte donation in Dublin
Por: Salma Umme, et al.
Publicado em: (2011-04-01)

Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF
Por: Sills E Scott, et al.
Publicado em: (2011-12-01)

30 years of Gender Studies - where we started out and where we're headed
Por: Helena Skálová
Publicado em: (2022-01-01)

Ovarian serous adenocarcinoma identified during IVF: diagnostic approach, surgical management, and reproductive outcome
Por: Gleeson Noreen C, et al.
Publicado em: (2009-05-01)

IVF for premature ovarian failure: first reported births using oocytes donated from a twin sister
Por: Sills Eric, et al.
Publicado em: (2010-03-01)

A Five-Decade Text Mining Analysis of Cochlear Implant Research: Where We Started and Where We Are Heading
Por: Idit Tessler, et al.
Publicado em: (2023-10-01)

Orchesting Inclusive Evaluation in Schools. Where We Could Start?
Por: Mª Amparo Calatayud
Publicado em: (2019-12-01)

Optimisation of thrombolysis treatment: where to start?
Por: Penaloza, M, et al.
Publicado em: (2012)

Neural information processing in cognition: we start to understand the orchestra, but where is the conductor?
Por: Guenther ePalm
Publicado em: (2016-01-01)

Where should we start to improve pediatric heart transplantation outcomes?
Por: Jinyoung Song
Publicado em: (2021-02-01)

NISQ computing: where are we and where do we go?
Por: Jonathan Wei Zhong Lau, et al.
Publicado em: (2022-09-01)

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
Por: Omarini C, et al.
Publicado em: (2018-01-01)

Lacrimal irrigation before intraocular surgery: Where are we today?
Por: Akshay Gopinathan Nair
Publicado em: (2024-10-01)

Vaccines against tuberculosis: where are we and where do we need to go?
Por: Tom H M Ottenhoff, et al.
Publicado em: (2012-01-01)

Entomology in South Africa: Where do we come from, where are we now and where are we going?
Por: Jan H. Giliomee
Publicado em: (2013-01-01)

Patient Blood Management: where to start?
Por: Liana Maria Torres de Araujo Azi, et al.
Publicado em: (2016-06-01)

Portrait of early science education in majority dual language learner classrooms: Where do we start?
Por: Brooke Rumper, et al.
Publicado em: (2021-10-01)

Where do we start? A baseline assessment for establishing health promoting schools in rural China
Por: X. She, et al.
Publicado em: (2014-09-01)

Where Do We Start? Building Consensus on Drivers of Health Sector Corruption in Nigeria and Ways to Address It
Por: Obinna Onwujekwe, et al.
Publicado em: (2020-07-01)

EdTech - Where Do I Start?
Por: Nancy Caukin
Publicado em: (2018-10-01)

Big change: what to do and where to start?
Por: L. Guzenko
Publicado em: (2005-10-01)

Ketogenic diet in the treatment of cancer – Where do we stand?
Por: Daniela D. Weber, et al.
Publicado em: (2020-03-01)

Start where you are /
Por: Gardner, Chris., (Chris P.), et al.
Publicado em: (2011)

Where it all started
Por: Long Zhang, et al.
Publicado em: (2023-04-01)

A descriptive study of oocyte, blood, and organ/tissue donation features among fertility patients in Ireland
Por: Sills, E, et al.
Publicado em: (2010)

A descriptive study of selected oocyte, blood and organ/tissue donation features among fertility patients in Ireland.
Por: Sills, E, et al.
Publicado em: (2010)

ColVI myopathies: where do we stand, where do we go?
Por: Allamand Valérie, et al.
Publicado em: (2011-09-01)

Treatment Of Diabetes In Bullous Pemphigoid Patients: Where Do We Stand?
Por: Maria Alexandre, et al.
Publicado em: (2023-01-01)

Where we are, where we are going
Por: Teresa Bermejo-Vicedo, et al.
Publicado em: (2020-03-01)

Where we are - where we are heading
Por: Andreas Schaffner
Publicado em: (2004-01-01)

“Guidelines Recommendations on the Treatment of Tricuspid Regurgitation. Where Are We and Where Do We Go With Transcatheter Valve Intervention”
Por: Alec Vahanian, et al.
Publicado em: (2018-04-01)

Therapeutic options for women with infertility before IVF
Por: Н. О. Данкович, et al.
Publicado em: (2017-04-01)

What are the Benefits of Diagnosing Endometriosis Before IVF?
Por: Chii Ruey Tzeng
Publicado em: (2023-12-01)

Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
Por: Christopher G Laine, et al.
Publicado em: (2020-01-01)